Case report: Exploring chemoradiotherapy-induced leukoencephalopathy with 7T imaging and quantitative susceptibility mapping.

7 Tesla brain damage chemoradiotherapy leukoencephalopathy neurotoxicity ultra-high field MRI

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2024
Historique:
received: 28 12 2023
accepted: 29 01 2024
medline: 29 2 2024
pubmed: 29 2 2024
entrez: 29 2 2024
Statut: epublish

Résumé

Chemotherapy and radiotherapy are widely used in the treatment of central nervous system tumors and acute lymphocytic leukemia even in the pediatric population. However, such treatments run the risk of a broad spectrum of cognitive and neurological deficits. Even though the correlation with cognitive decline is still not clear, neuroradiological defects linked to white matter injury and vasculopathies may be identified. Thanks to the use of 7T MRI it is possible to better define the vascular pattern of the brain lesions with the added advantage of identifying their characteristics and anatomical localization, which, however, are not evident with a conventional brain scan. Moreover, the use of Quantitative Susceptibility Mapping (QSM) makes it possible to discriminate between calcium deposits on vessels (chemo-radiation-induced) and hemoglobin deposition in radio-induced cavernomas, speculating, as a result, about the pathophysiology of iatrogenic brain damage. We describe the case of a 9 year-old boy with a T-type acute lymphoid leukemia who had previously been treated with polychemotherapy and high-dose RT. To better define the child's neuroradiological pattern, 7T MRI and QSM were performed in addition to conventional imaging examinations. Our case report suggests the potential usefulness of a QSM study to distinguish radio-induced vascular malformations from mineralizing microangiopathy.

Identifiants

pubmed: 38419703
doi: 10.3389/fneur.2024.1362704
pmc: PMC10899325
doi:

Types de publication

Case Reports

Langues

eng

Pagination

1362704

Informations de copyright

Copyright © 2024 Celardo, Scaffei, Buchignani, Donatelli, Costagli, Cristofani, Canapicchi, Pasquariello, Tosetti, Battini and Biagi.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Auteurs

Gaetano Celardo (G)

Department of Developmental Neuroscience, IRCCS Stella Maris Foundation, Pisa, Italy.
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Elena Scaffei (E)

Department of Developmental Neuroscience, IRCCS Stella Maris Foundation, Pisa, Italy.

Bianca Buchignani (B)

Department of Developmental Neuroscience, IRCCS Stella Maris Foundation, Pisa, Italy.
Department of Translational Research and of New Surgical and Medical Technologies Pisa University, Pisa, Italy.

Graziella Donatelli (G)

Department of Translational Research and of New Surgical and Medical Technologies Pisa University, Pisa, Italy.
Imago 7 Research Foundation, Pisa, Italy.

Mauro Costagli (M)

Department of Developmental Neuroscience, IRCCS Stella Maris Foundation, Pisa, Italy.
Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.

Paola Cristofani (P)

Department of Developmental Neuroscience, IRCCS Stella Maris Foundation, Pisa, Italy.

Raffaello Canapicchi (R)

Department of Developmental Neuroscience, IRCCS Stella Maris Foundation, Pisa, Italy.

Rosa Pasquariello (R)

Department of Developmental Neuroscience, IRCCS Stella Maris Foundation, Pisa, Italy.

Michela Tosetti (M)

Department of Developmental Neuroscience, IRCCS Stella Maris Foundation, Pisa, Italy.

Roberta Battini (R)

Department of Developmental Neuroscience, IRCCS Stella Maris Foundation, Pisa, Italy.
Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Laura Biagi (L)

Department of Developmental Neuroscience, IRCCS Stella Maris Foundation, Pisa, Italy.

Classifications MeSH